Transgene (Production Asset) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Transgene (Production Asset) General Information

Description

Production unit in Strasbourg, France. The unit is designed and equipped to manufacture clinical lots of pharmaceuticals and vaccines using viral vectors.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Strasbourg
  • France
Primary Industry
Buildings and Property
Acquirer
Advanced Bioscience Laboratories
Vertical(s)
Manufacturing
Corporate Office
  • Strasbourg
  • France

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Transgene (Production Asset) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Transgene (Production Asset)‘s full profile, request access.

Request a free trial

Transgene (Production Asset) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Transgene (Production Asset)‘s full profile, request access.

Request a free trial

Transgene (Production Asset) FAQs

  • Where is Transgene (Production Asset) headquartered?

    Transgene (Production Asset) is headquartered in Strasbourg, France.

  • What industry is Transgene (Production Asset) in?

    Transgene (Production Asset)’s primary industry is Buildings and Property.

  • Is Transgene (Production Asset) a private or public company?

    Transgene (Production Asset) is a Private company.

  • What is Transgene (Production Asset)’s current revenue?

    The current revenue for Transgene (Production Asset) is 000000.

  • Who are Transgene (Production Asset)’s investors?

    Transgene has invested in Transgene (Production Asset).

  • When was Transgene (Production Asset) acquired?

    Transgene (Production Asset) was acquired on 03-Feb-2016.

  • Who acquired Transgene (Production Asset)?

    Transgene (Production Asset) was acquired by Advanced Bioscience Laboratories.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »